IL1R1 and acute respiratory distress syndrome: Moreover, short acting substances, e.g. IL-1R-blockade with anakinra for which positive data exist from other neutrophilic hyperinflammatory conditions such as Still's disease with ARDS and septic shock deserves special consideration, as it allows the therapy to be quickly de-escalated 41,42.